サマリー

Women’s health diagnostics market is growing due to the increasing prevalence of osteoarthritis, ovarian cancer, breast cancer and cervical cancer.

Market Analysis and Insights: Global Women’s Health Diagnostics Market
The global Women’s Health Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Women’s Health Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Women’s Health Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Women’s Health Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Women’s Health Diagnostics market.

Global Women’s Health Diagnostics Scope and Market Size
Women’s Health Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Women’s Health Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnostic Devices
Diagnostic Tests

Segment by Application
Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Roche
Philips
Siemens
Perkinelmer Inc.
Alere Inc.
GE Healthcare
Becton, Dickinson and Company
Biomerieux SA
Quest Diagnostics Inc.
Hologic, Inc.

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women’s Health Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnostic Devices
1.2.3 Diagnostic Tests
1.3 Market by Application
1.3.1 Global Women’s Health Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Infectious Disease Testing
1.3.4 Osteoporosis Testing
1.3.5 Pregnancy and Fertility Testing
1.3.6 Sexually Transmitted Disease Testing
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Women’s Health Diagnostics Market Perspective (2016-2027)
2.2 Women’s Health Diagnostics Growth Trends by Regions
2.2.1 Women’s Health Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Women’s Health Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Women’s Health Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Women’s Health Diagnostics Industry Dynamic
2.3.1 Women’s Health Diagnostics Market Trends
2.3.2 Women’s Health Diagnostics Market Drivers
2.3.3 Women’s Health Diagnostics Market Challenges
2.3.4 Women’s Health Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Women’s Health Diagnostics Players by Revenue
3.1.1 Global Top Women’s Health Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Women’s Health Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Women’s Health Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Women’s Health Diagnostics Revenue
3.4 Global Women’s Health Diagnostics Market Concentration Ratio
3.4.1 Global Women’s Health Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Women’s Health Diagnostics Revenue in 2020
3.5 Women’s Health Diagnostics Key Players Head office and Area Served
3.6 Key Players Women’s Health Diagnostics Product Solution and Service
3.7 Date of Enter into Women’s Health Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Women’s Health Diagnostics Breakdown Data by Type
4.1 Global Women’s Health Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Women’s Health Diagnostics Forecasted Market Size by Type (2022-2027)

5 Women’s Health Diagnostics Breakdown Data by Application
5.1 Global Women’s Health Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Women’s Health Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Women’s Health Diagnostics Market Size (2016-2027)
6.2 North America Women’s Health Diagnostics Market Size by Type
6.2.1 North America Women’s Health Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Women’s Health Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Women’s Health Diagnostics Market Size by Type (2016-2027)
6.3 North America Women’s Health Diagnostics Market Size by Application
6.3.1 North America Women’s Health Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Women’s Health Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Women’s Health Diagnostics Market Size by Application (2016-2027)
6.4 North America Women’s Health Diagnostics Market Size by Country
6.4.1 North America Women’s Health Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Women’s Health Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Women’s Health Diagnostics Market Size (2016-2027)
7.2 Europe Women’s Health Diagnostics Market Size by Type
7.2.1 Europe Women’s Health Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Women’s Health Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Women’s Health Diagnostics Market Size by Type (2016-2027)
7.3 Europe Women’s Health Diagnostics Market Size by Application
7.3.1 Europe Women’s Health Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Women’s Health Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Women’s Health Diagnostics Market Size by Application (2016-2027)
7.4 Europe Women’s Health Diagnostics Market Size by Country
7.4.1 Europe Women’s Health Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Women’s Health Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Women’s Health Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Women’s Health Diagnostics Market Size by Type
8.2.1 Asia-Pacific Women’s Health Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Women’s Health Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Women’s Health Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Women’s Health Diagnostics Market Size by Application
8.3.1 Asia-Pacific Women’s Health Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Women’s Health Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Women’s Health Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Women’s Health Diagnostics Market Size by Region
8.4.1 Asia-Pacific Women’s Health Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Women’s Health Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Women’s Health Diagnostics Market Size (2016-2027)
9.2 Latin America Women’s Health Diagnostics Market Size by Type
9.2.1 Latin America Women’s Health Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Women’s Health Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Women’s Health Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Women’s Health Diagnostics Market Size by Application
9.3.1 Latin America Women’s Health Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Women’s Health Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Women’s Health Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Women’s Health Diagnostics Market Size by Country
9.4.1 Latin America Women’s Health Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Women’s Health Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Women’s Health Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Women’s Health Diagnostics Market Size by Type
10.2.1 Middle East & Africa Women’s Health Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Women’s Health Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Women’s Health Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Women’s Health Diagnostics Market Size by Application
10.3.1 Middle East & Africa Women’s Health Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Women’s Health Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Women’s Health Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Women’s Health Diagnostics Market Size by Country
10.4.1 Middle East & Africa Women’s Health Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Women’s Health Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Women’s Health Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Women’s Health Diagnostics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Women’s Health Diagnostics Introduction
11.2.4 Roche Revenue in Women’s Health Diagnostics Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Philips
11.3.1 Philips Company Details
11.3.2 Philips Business Overview
11.3.3 Philips Women’s Health Diagnostics Introduction
11.3.4 Philips Revenue in Women’s Health Diagnostics Business (2016-2021)
11.3.5 Philips Recent Development
11.4 Siemens
11.4.1 Siemens Company Details
11.4.2 Siemens Business Overview
11.4.3 Siemens Women’s Health Diagnostics Introduction
11.4.4 Siemens Revenue in Women’s Health Diagnostics Business (2016-2021)
11.4.5 Siemens Recent Development
11.5 Perkinelmer Inc.
11.5.1 Perkinelmer Inc. Company Details
11.5.2 Perkinelmer Inc. Business Overview
11.5.3 Perkinelmer Inc. Women’s Health Diagnostics Introduction
11.5.4 Perkinelmer Inc. Revenue in Women’s Health Diagnostics Business (2016-2021)
11.5.5 Perkinelmer Inc. Recent Development
11.6 Alere Inc.
11.6.1 Alere Inc. Company Details
11.6.2 Alere Inc. Business Overview
11.6.3 Alere Inc. Women’s Health Diagnostics Introduction
11.6.4 Alere Inc. Revenue in Women’s Health Diagnostics Business (2016-2021)
11.6.5 Alere Inc. Recent Development
11.7 GE Healthcare
11.7.1 GE Healthcare Company Details
11.7.2 GE Healthcare Business Overview
11.7.3 GE Healthcare Women’s Health Diagnostics Introduction
11.7.4 GE Healthcare Revenue in Women’s Health Diagnostics Business (2016-2021)
11.7.5 GE Healthcare Recent Development
11.8 Becton, Dickinson and Company
11.8.1 Becton, Dickinson and Company Company Details
11.8.2 Becton, Dickinson and Company Business Overview
11.8.3 Becton, Dickinson and Company Women’s Health Diagnostics Introduction
11.8.4 Becton, Dickinson and Company Revenue in Women’s Health Diagnostics Business (2016-2021)
11.8.5 Becton, Dickinson and Company Recent Development
11.9 Biomerieux SA
11.9.1 Biomerieux SA Company Details
11.9.2 Biomerieux SA Business Overview
11.9.3 Biomerieux SA Women’s Health Diagnostics Introduction
11.9.4 Biomerieux SA Revenue in Women’s Health Diagnostics Business (2016-2021)
11.9.5 Biomerieux SA Recent Development
11.10 Quest Diagnostics Inc.
11.10.1 Quest Diagnostics Inc. Company Details
11.10.2 Quest Diagnostics Inc. Business Overview
11.10.3 Quest Diagnostics Inc. Women’s Health Diagnostics Introduction
11.10.4 Quest Diagnostics Inc. Revenue in Women’s Health Diagnostics Business (2016-2021)
11.10.5 Quest Diagnostics Inc. Recent Development
11.11 Hologic, Inc.
11.11.1 Hologic, Inc. Company Details
11.11.2 Hologic, Inc. Business Overview
11.11.3 Hologic, Inc. Women’s Health Diagnostics Introduction
11.11.4 Hologic, Inc. Revenue in Women’s Health Diagnostics Business (2016-2021)
11.11.5 Hologic, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details